Abstract |
We investigated the efficacy of Gosyajinkigan in 20 patients with prostatic disease, in whom pollakisuria was not improved by treatment with drugs for lower urinary tract symptoms. Four and 8 weeks after treatment, the urinary frequency was significantly improved during both daytime and night. The efficacy rates for diurnal frequency and nocturia were 45% and 65%, respectively. The International Prostate Symptom Score (IPSS) was decreased 4 weeks after treatment, and the parameters of uroflowmetry, the residual urine volume and quality of life score were improved 8 weeks after therapy. It was concluded that Goshajinkigan was effective for pollakisuria with prostatic disease, and the administration of the agent for 8 weeks or longer was needed to improve lower urinary tract symptoms.
|
Authors | Akihiko Watanabe, Takuya Akashi, Yasuyoshi Fujiuchi, Ichiro Mizuno, Osamu Nagakawa, Hideki Fuse |
Journal | Hinyokika kiyo. Acta urologica Japonica
(Hinyokika Kiyo)
Vol. 52
Issue 3
Pg. 197-201
(Mar 2006)
ISSN: 0018-1994 [Print] Japan |
PMID | 16617873
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Drug Administration Schedule
- Drugs, Chinese Herbal
(therapeutic use)
- Humans
- Male
- Middle Aged
- Prostatic Diseases
(complications)
- Prostatic Hyperplasia
(complications)
- Quality of Life
- Treatment Outcome
- Urination Disorders
(drug therapy, etiology)
- Urodynamics
|